Click for best price
Swine Mycoplasma Pneumonia Live Vaccine Market Size, Share 2024
| Market size in 2023 |
US$ 220.2 million
|
Forecast Market size by 2030 |
US$ 329.6 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
73 Pages |
The global Swine Mycoplasma Pneumonia Live Vaccine market was valued at US$ 220.2 million in 2023 and is projected to reach US$ 329.6 million by 2030, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
168 Strains Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Swine Mycoplasma Pneumonia Live Vaccine include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Pneumonia Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Pneumonia Live Vaccine. This report contains market size and forecasts of Swine Mycoplasma Pneumonia Live Vaccine in global, including the following market information:
- Global Swine Mycoplasma Pneumonia Live Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Swine Mycoplasma Pneumonia Live Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Swine Mycoplasma Pneumonia Live Vaccine companies in 2023 (%)
We surveyed the Swine Mycoplasma Pneumonia Live Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Mycoplasma Pneumonia Live Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine Market Segment Percentages, by Type, 2023 (%)
- 168 Strains
- RM48 Strains
- Other
Global Swine Mycoplasma Pneumonia Live Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine Market Segment Percentages, by Application, 2023 (%)
Global Swine Mycoplasma Pneumonia Live Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Swine Mycoplasma Pneumonia Live Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Swine Mycoplasma Pneumonia Live Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Swine Mycoplasma Pneumonia Live Vaccine revenues share in global market, 2023 (%)
- Key companies Swine Mycoplasma Pneumonia Live Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Swine Mycoplasma Pneumonia Live Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zoetis
- Boehringer Ingelheim
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Qilu Animal Health Products
- Guangdong Winsun Bio-Pharmaceutical
- Jilin HeYuan Bioengineering
- Jofunhwa Biotechnology
- Including or excluding key companies relevant to your analysis.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Mycoplasma Pneumonia Live Vaccine, market overview.
Chapter 2: Global Swine Mycoplasma Pneumonia Live Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Swine Mycoplasma Pneumonia Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Mycoplasma Pneumonia Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Swine Mycoplasma Pneumonia Live Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Swine Mycoplasma Pneumonia Live Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 220.2 million
|
| Forecast Market size by 2030 |
US$ 329.6 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Swine Mycoplasma Pneumonia Live Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Swine Mycoplasma Pneumonia Live Vaccine Overall Market Size
2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size: 2023 VS 2030
2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Swine Mycoplasma Pneumonia Live Vaccine Players in Global Market
3.2 Top Global Swine Mycoplasma Pneumonia Live Vaccine Companies Ranked by Revenue
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Companies
3.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Companies
3.5 Global Swine Mycoplasma Pneumonia Live Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Swine Mycoplasma Pneumonia Live Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Swine Mycoplasma Pneumonia Live Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Swine Mycoplasma Pneumonia Live Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Swine Mycoplasma Pneumonia Live Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Markets, 2023 & 2030
4.1.2 168 Strains
4.1.3 RM48 Strains
4.1.4 Other
4.2 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue & Forecasts
4.2.1 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales & Forecasts
4.3.1 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2024
4.3.2 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2025-2030
4.3.3 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2023 & 2030
5.1.2 Piglets
5.1.3 Adult Pigs
5.2 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue & Forecasts
5.2.1 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales & Forecasts
5.3.1 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2024
5.3.2 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2025-2030
5.3.3 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue & Forecasts
6.2.1 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales & Forecasts
6.3.1 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2024
6.3.2 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales, 2025-2030
6.3.3 By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2030
6.4.3 US Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.4.4 Canada Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.4.5 Mexico Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2030
6.5.3 Germany Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.4 France Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.5 U.K. Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.6 Italy Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.7 Russia Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.5.9 Benelux Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2030
6.6.3 China Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.6.4 Japan Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.6.5 South Korea Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.6.7 India Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2030
6.7.3 Brazil Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.7.4 Argentina Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales, 2019-2030
6.8.3 Turkey Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.8.4 Israel Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
6.8.6 UAE Swine Mycoplasma Pneumonia Live Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Zoetis
7.1.1 Zoetis Company Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Zoetis Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Merck Key News & Latest Developments
7.4 HIPRA
7.4.1 HIPRA Company Summary
7.4.2 HIPRA Business Overview
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 HIPRA Key News & Latest Developments
7.5 Ceva Sant? Animale
7.5.1 Ceva Sant? Animale Company Summary
7.5.2 Ceva Sant? Animale Business Overview
7.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.5.4 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Ceva Sant? Animale Key News & Latest Developments
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Company Summary
7.6.2 Harbin Pharmaceutical Group Business Overview
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Company Summary
7.7.2 Qilu Animal Health Products Business Overview
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Qilu Animal Health Products Key News & Latest Developments
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Company Summary
7.8.2 Guangdong Winsun Bio-Pharmaceutical Business Overview
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 Guangdong Winsun Bio-Pharmaceutical Key News & Latest Developments
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Company Summary
7.9.2 Jilin HeYuan Bioengineering Business Overview
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 Jilin HeYuan Bioengineering Key News & Latest Developments
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Company Summary
7.10.2 Jofunhwa Biotechnology Business Overview
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Major Product Offerings
7.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 Jofunhwa Biotechnology Key News & Latest Developments
8 Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity, Analysis
8.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity, 2019-2030
8.2 Swine Mycoplasma Pneumonia Live Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Swine Mycoplasma Pneumonia Live Vaccine Supply Chain Analysis
10.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Value Chain
10.2 Swine Mycoplasma Pneumonia Live Vaccine Upstream Market
10.3 Swine Mycoplasma Pneumonia Live Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Swine Mycoplasma Pneumonia Live Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Swine Mycoplasma Pneumonia Live Vaccine in Global Market
Table 2. Top Swine Mycoplasma Pneumonia Live Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Type
Table 9. List of Global Tier 1 Swine Mycoplasma Pneumonia Live Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Mycoplasma Pneumonia Live Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales, (K Units), 2025-2030
Table 46. Zoetis Company Summary
Table 47. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 48. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Zoetis Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 52. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 56. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. HIPRA Company Summary
Table 59. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 60. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. HIPRA Key News & Latest Developments
Table 62. Ceva Sant? Animale Company Summary
Table 63. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 64. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Ceva Sant? Animale Key News & Latest Developments
Table 66. Harbin Pharmaceutical Group Company Summary
Table 67. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 68. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Harbin Pharmaceutical Group Key News & Latest Developments
Table 70. Qilu Animal Health Products Company Summary
Table 71. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 72. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Qilu Animal Health Products Key News & Latest Developments
Table 74. Guangdong Winsun Bio-Pharmaceutical Company Summary
Table 75. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 76. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Guangdong Winsun Bio-Pharmaceutical Key News & Latest Developments
Table 78. Jilin HeYuan Bioengineering Company Summary
Table 79. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 80. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Jilin HeYuan Bioengineering Key News & Latest Developments
Table 82. Jofunhwa Biotechnology Company Summary
Table 83. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 84. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Jofunhwa Biotechnology Key News & Latest Developments
Table 86. Swine Mycoplasma Pneumonia Live Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 87. Global Swine Mycoplasma Pneumonia Live Vaccine Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global Swine Mycoplasma Pneumonia Live Vaccine Production by Region, 2019-2024 (K Units)
Table 89. Global Swine Mycoplasma Pneumonia Live Vaccine Production by Region, 2025-2030 (K Units)
Table 90. Swine Mycoplasma Pneumonia Live Vaccine Market Opportunities & Trends in Global Market
Table 91. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers in Global Market
Table 92. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints in Global Market
Table 93. Swine Mycoplasma Pneumonia Live Vaccine Raw Materials
Table 94. Swine Mycoplasma Pneumonia Live Vaccine Raw Materials Suppliers in Global Market
Table 95. Typical Swine Mycoplasma Pneumonia Live Vaccine Downstream
Table 96. Swine Mycoplasma Pneumonia Live Vaccine Downstream Clients in Global Market
Table 97. Swine Mycoplasma Pneumonia Live Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Segment by Type in 2023
Figure 2. Swine Mycoplasma Pneumonia Live Vaccine Segment by Application in 2023
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. Swine Mycoplasma Pneumonia Live Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
Figure 9. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 23. US Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 28. Germany Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 37. China Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Swine Mycoplasma Pneumonia Live Vaccine by Region, 2023 VS 2030
Figure 54. Swine Mycoplasma Pneumonia Live Vaccine Industry Value Chain
Figure 55. Marketing Channels
